Contribution of intrinsic fluorescence to the design of a new 3D-printed implant for releasing SDABS - Archive ouverte HAL Access content directly
Journal Articles Pharmaceutics Year : 2020

Contribution of intrinsic fluorescence to the design of a new 3D-printed implant for releasing SDABS

(1, 2) , (2) , (2) , (3) , (2) , (1)
1
2
3

Abstract

Single-domain antibodies (sdAbs) offer great features such as increased stability but are hampered by a limited serum half-life. Many strategies have been developed to improve the sdAb half-life, such as protein engineering and controlled release systems (CRS). In our study, we designed a new product that combined a hydrogel with a 3D-printed implant. The results demonstrate the implant's ability to sustain sdAb release up to 13 days through a reduced initial burst release followed by a continuous release. Furthermore, formulation screening helped to identify the best sdAb formulation conditions and improved our understanding of our CRS. Through the screening step, we gained knowledge about the influence of the choice of polymer and about potential interactions between the sdAb and the polymer. To conclude, this feasibility study confirmed the ability of our CRS to extend sdAb release and established the fundamental role of formulation screening for maximizing knowledge about our CRS.
Fichier principal
Vignette du fichier
Nicolas et al. - 2020 - Contribution of Intrinsic Fluorescence to the Desi.pdf (2.84 Mo) Télécharger le fichier
Origin : Publisher files allowed on an open archive
Loading...

Dates and versions

hal-02964412 , version 1 (12-10-2020)

Licence

Attribution - CC BY 4.0

Identifiers

Cite

Alexandre Nicolas, Alice Dejoux, Cécile Poirier, Nicolas Aubrey, Jean-Manuel Péan, et al.. Contribution of intrinsic fluorescence to the design of a new 3D-printed implant for releasing SDABS. Pharmaceutics, 2020, 12, 20 p. ⟨10.3390/pharmaceutics12100921⟩. ⟨hal-02964412⟩
54 View
54 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More